OctoPlus' Licensee Biolex, Inc. Makes Third Presentation At EASL Confirming Locteron's Superior Product Profile
4/19/2010 10:15:15 AM
More...
|
Biolex, Inc. Pulls Planned IPO Due to Market Conditions
2/4/2008 7:03:41 AM
More...
|
Biolex, Inc. Announces Initiation Of Locteron(TM) Phase 2 Clinical Study In Chronic Hepatitis C
1/30/2007 11:17:01 AM
More...
|
Biolex, Inc. Announces Publication In Nature Biotechnology Demonstrating Potential To Produce Monoclonal Antibodies With Increased Potency And Efficacy
11/28/2006 10:48:12 AM
More...
|
Biolex, Inc. Featured At The 9th Annual Facilities For Mammalian Cell Product Conference
10/18/2006 11:08:16 AM
More...
|
Biolex Therapeutics Announces Positive Phase 1 Results For Hepatitis C Product Candidate Locteron(TM)
4/27/2006 10:19:30 AM
More...
|
Biolex Therapeutics Announces Expansion Of Medarex, Inc. (MEDX) Collaboration
4/11/2006 10:31:46 AM
More...
|
Biolex Therapeutics Receives Prestigious Award For Manufacturing Facility
3/22/2006 11:17:43 AM
More...
|
Biolex Therapeutics Presents Results Highlighting Benefits Of Locteron(TM) At 'Breakthroughs In Hepatitis' Session
2/15/2006 10:42:45 AM
More...
|
Biolex Therapeutics Announces Recruitment Of Three Key Management Team Additions To Accelerate Commercialization Of Lead Programs
11/16/2005 11:56:01 AM
More...
|
|